Literature DB >> 20670824

Hunting-ton for new proteases: MMPs as the new target?

Ashu Johri1, M Flint Beal.   

Abstract

Mutant huntingtin proteolysis mediated by various proteases plays a key role in Huntington's disease (HD) pathogenesis. In this issue of Neuron, Miller et al. have identified 11 proteases, including matrix metalloproteinases (MMPs), that when inhibited reduce huntingtin proteolysis and produce beneficial therapeutic effects. These findings provide new insights into huntingtin proteolysis and its potential as a therapeutic target.

Entities:  

Year:  2010        PMID: 20670824      PMCID: PMC3094731          DOI: 10.1016/j.neuron.2010.07.011

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  15 in total

1.  Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.

Authors:  A Yamamoto; J J Lucas; R Hen
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

2.  Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10.

Authors:  Shurong Chang; Bryan D Young; Shijie Li; Xiaoxia Qi; James A Richardson; Eric N Olson
Journal:  Cell       Date:  2006-07-28       Impact factor: 41.582

3.  Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease.

Authors:  John P Miller; Jennifer Holcomb; Ismael Al-Ramahi; Maria de Haro; Juliette Gafni; Ningzhe Zhang; Eugene Kim; Mario Sanhueza; Cameron Torcassi; Seung Kwak; Juan Botas; Robert E Hughes; Lisa M Ellerby
Journal:  Neuron       Date:  2010-07-29       Impact factor: 17.173

4.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

5.  Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.

Authors:  L Mangiarini; K Sathasivam; M Seller; B Cozens; A Harper; C Hetherington; M Lawton; Y Trottier; H Lehrach; S W Davies; G P Bates
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

Review 6.  Huntington disease: new insights on the role of huntingtin cleavage.

Authors:  C L Wellington; B R Leavitt; M R Hayden
Journal:  J Neural Transm Suppl       Date:  2000

7.  The matrix metalloproteinases inhibitor Ro 28-2653 [correction of Ro 26-2853] extends survival in transgenic ALS mice.

Authors:  Stefan Lorenzl; Sabine Narr; Barabara Angele; Hans Willi Krell; Jason Gregorio; Mahmoud Kiaei; Hans-Walter Pfister; M Flint Beal
Journal:  Exp Neurol       Date:  2006-03-03       Impact factor: 5.330

8.  Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits.

Authors:  M DiFiglia; M Sena-Esteves; K Chase; E Sapp; E Pfister; M Sass; J Yoder; P Reeves; R K Pandey; K G Rajeev; M Manoharan; D W Y Sah; P D Zamore; N Aronin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-16       Impact factor: 11.205

9.  Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions.

Authors:  Astrid Lunkes; Katrin S Lindenberg; Léa Ben-Haïem; Chantal Weber; Didier Devys; G Bernhard Landwehrmeyer; Jean-Louis Mandel; Yvon Trottier
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

10.  Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus.

Authors:  Juliette Gafni; Evan Hermel; Jessica E Young; Cheryl L Wellington; Michael R Hayden; Lisa M Ellerby
Journal:  J Biol Chem       Date:  2004-02-23       Impact factor: 5.157

View more
  3 in total

Review 1.  Antioxidants in Huntington's disease.

Authors:  Ashu Johri; M Flint Beal
Journal:  Biochim Biophys Acta       Date:  2011-11-23

Review 2.  An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity.

Authors:  G Cisbani; F Cicchetti
Journal:  Cell Death Dis       Date:  2012-08-30       Impact factor: 8.469

3.  Matrix metalloproteinases in the mouse retina: a comparative study of expression patterns and MMP antibodies.

Authors:  Lies De Groef; Lien Andries; Kim Lemmens; Inge Van Hove; Lieve Moons
Journal:  BMC Ophthalmol       Date:  2015-12-29       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.